Dietary quercetin combining intratumoral doxorubicin injection synergistically induces rejection of established breast cancer in mice

International Immunopharmacology

Volumn 10, Issue 7, 2010, Pages 819-826

  Du, Gangjun ^a,b   Lin, Haihong ^a   Yang, Yiming ^b   Zhang, Shuo ^a   Wu, Xianchuang ^a   Wang, Mei ^a   Ji, Liyan ^a   Lu, Linlin ^a   Yu, Lijuan ^a   Han, Guang ^a  

^a HENAN UNIVERSITY   (China)

^b Kaifeng Institute of Education   (China)

Author keywords

Breast cancer; Dietary adjuvant; Doxorubicin; Quercetin; Tumor rejection

Indexed keywords

DOXORUBICIN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; QUERCETIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BAGG ALBINO MOUSE; BREAST CANCER; CANCER COMBINATION CHEMOTHERAPY; CANCER INHIBITION; CANCER MODEL; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; DIET SUPPLEMENTATION; DISEASE FREE SURVIVAL; DRUG EFFICACY; DRUG POTENCY; DRUG POTENTIATION; DRUG STRUCTURE; FEMALE; IMMUNOSURVEILLANCE; LUNG METASTASIS; LYMPHOCYTE PROLIFERATION; METASTASIS INHIBITION; MONOTHERAPY; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SURVIVAL TIME; TH1 CELL; TH2 CELL; TUMOR VOLUME;

ANIMALS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CELL GROWTH PROCESSES; CELL LINE, TUMOR; CYTOTOXICITY, IMMUNOLOGIC; DOXORUBICIN; DRUG SYNERGISM; FEMALE; HUMANS; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM TRANSPLANTATION; QUERCETIN; T-LYMPHOCYTES;

EID: 77953028951     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2010.04.018     Document Type: Article

References (35)

1. Jemal A., Siegel R., Ward E., Hao Y., Xu J., Murray T., et al. Cancer statistics, 2008. CA-Cancer J Clin 58 (2008) 71-96
2. Mannino M., and Yarnold J.R. Local relapse rates are falling after breast conserving surgery and systemic therapy for early breast cancer: can radiotherapy ever be safely withheld?. Radiother Oncol 90 (2009) 14-22
3. Xu X.R., and Chen J. One-carbon metabolism and breast cancer: an epidemiological perspective. J Genet Genomics 36 (2009) 203-214
4. Hirvonen T., Mennen L.I., de Bree A., Castetbon K., Galan P., Bertrais S., et al. Consumption of antioxidant-rich beverages and risk for breast cancer in French women. Ann Epidemiol 16 (2006) 503-508
5. Ullmannova V., and Popescu N.C. Inhibition of cell proliferation, induction of apoptosis, reactivation of DLC1, and modulation of other gene expression by dietary flavone in breast cancer cell lines. Cancer Detect Prev 31 (2007) 110-118
6. Chamras H., Ardashian A., Heber D., and Glaspy J.A. Fatty acid modulation of MCF-7 human breast cancer cell proliferation, apoptosis and differentiation. J Nutr Biochem 13 (2002) 711-716
7. Gopalakrishnan A. Tony Kong AN. Anticarcinogenesis by dietary phytochemicals: cytoprotection by Nrf2 in normal cells and cytotoxicity by modulation of transcription factors NF-κB and AP-1 in abnormal cancer cells. Food Chem Toxicol 46 (2008) 1257-1270
8. 2 production and COX-2 protein levels in MDA-MB-231 breast cancer cell cultures. J Nutr Biochem 16 (2005) 184-192
9. Walle T., Ta N., Kawamori To., Wen X., Tsuji P.A., and Walle U.K. Cancer chemopreventive properties of orally bioavailable flavonoids-methylated versus unmethylated flavones. Biochem Pharmacol 73 (2007) 1288-1296
10. Murakami A., Ashida H., and Terao J. Multitargeted cancer prevention by quercetin. Cancer Lett 269 (2008) 315-325
11. Duraj J., Zazrivcova K., Bodo J., Sulikova M., and Sedlak J. Flavonoid quercetin, but not apigenin or luteolin, induced apoptosis in human myeloid leukemia cells and their resistant variants. Neoplasma 52 (2005) 273-279
12. Granado-Serrano A.B., Marti{dotless}'n M.A., Bravo L., Goya L., and Ramos S. Quercetin induces apoptosis via caspase activation, regulation of Bcl-2, and inhibition of PI-3-kinase/Akt and ERK pathways in a human hepatoma cell line (HepG2). J Nutr 136 (2006) 2715-2721
13. Akbas S.H., Timur M., and Ozben T. The effect of quercetin on topotecan cytotoxicity in MCF-7 and MDA-MB 231 human breast cancer cells. J Surg Res 125 (2005) 49-55
14. Gianni L., and Valagussa P. Anthracyclines and early breast cancer: the end of an era?. J Clin Oncol 27 (2009) 1155-1157
15. Obeid M., Tesniere A., Ghiringhelli F., Fimia G.M., Apetoh L., Perfettini J.L., et al. Calreticulin exposure dictates the immunogenicity of cancer cell death. Nat Med 13 (2007) 54-61
16. Du G.J., Lin H.H., Wang M., Zhang S., Wu C.C., Lu L.L., et al. Quercetin greatly improved therapeutic index of doxorubicin against 4 T1 breast cancer by its opposing effects on HIF-1α in tumor and normal cells. Cancer Chemother Pharmacol 65 (2010) 277-287
17. Aslakson C., and Miller F. Selective events in the metastatic process defined by analysis of the sequential dissemination of subpopulations of a mouse mammary tumor. Cancer Res 52 (1992) 1399-1405
18. Zhang Q., Zeng X.K., Guo J.X., and Wang X. Oxidant stress mechanism of homocysteine potentiating Con A induced proliferation in murine splenic T lymphocytes. Cardiovascular Res 53 (2002) 1035-1042
19. Tang N., Du G.J., Wang N., Liu C.C., Hang H.Y., and Liang W. Improving penetration in tumors with nano assemblies of phospholipids and doxorubicin. J Natl Cancer Inst 99 (2007) 1004-1015
20. Tsang Y.W., Chi K.H., Hu C.J., Tseng C.L., Tseng F.W., and Wang Y.S. Chemotherapy-induced immunosuppression is restored by a fermented soybean extract: a proof of concept clinical trial. Nutr Res 27 (2007) 679-684
21. Baum M., Ernst E., Lejeune S., and Horneber M. Role of complementary and alternative medicine in the care of patients with breast cancer: report of the European Society of Mastology (EUSOMA) Workshop, Florence, Italy, December 2004. Eur J Cancer 42 (2006) 1702-1710
22. Pasanisi P., Villarini A., Bruno E., Raimondi M., Gargano G., and Berrino F. Benefits of a healthy diet for cancer patients. European Journal of Cancer Supplements 7 2 (2008) 45
23. Wilms L.C., Hollman P.C., Boots A.W., and Kleinjans J.C. Protection by quercetin and quercetin-rich fruit juice against induction of oxidative DNA damage and formation of BPDE-DNA adducts in human lymphocytes. Mutat Res 582 (2005) 155-162
24. Staveley-O' Carroll K., Sotomayor E., Montgomery J., Borrello I., Hwang L., Fein S., et al. Induction of antigen-specific T cell anergy: an early event in the course of tumor progression. Proc Natl Acad Sci U S A 95 (1998) 1178-1183
25. Romagnani S. Short analytical review: Th1 and Th2 in human disease. Clin Immunol Immunolpathol 80 (1996) 225-235
26. Clerici M., Merola M., Ferrario E., Trabattoni D., Villa M.L., Stefanon B., et al. Cytokine production patterns in cervical intraepithelial neoplasia: association with human papillomavirus infection. J Natl Cancer Inst 89 (1997) 245-250
27. Manach C., Morand C., Crespy V., Demigne C., Texier O., Régérat F., et al. Quercetin is recovered in human plasma as conjugated derivatives which retain anti-oxidant properties. FEBS Lett 426 (1998) 331-336
28. Hollmanay P.C., van Trijp J.M., Mengelers M.J., de Vries J.H., and Katan M.B. Bioavailability of the dietary antioxidant flavonol quercetin in man. Cancer Lett 114 (1997) 139-140
29. EJr M., Kandaswami C., and Theoharides T.C. The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer. Pharmacol Rev 52 (2000) 673-751
30. Ruiz M.J., Fernández M., Picó Y., Mañes J., Asensi M., Carda C., et al. Dietary administration of high doses of pterostilbene and quercetin to mice is not toxic. J Agric Food Chem 57 (2009) 3180-3186
31. Harwood M., Danielewska-Nikiel B., Borzelleca J.F., Flamm G.W., Williams G.M., and Lines T.C. A critical review of the data related to the safety of quercetin and lack of evidence of in vivo toxicity, including lack of genotoxic/carcinogenic properties. Food Chem Toxicol. 45 (2007) 2179-2205
32. Utesch D., Feige K., Dasenbrock J., Broschard T.H., Harwood M., Danielewska-Nikiel B., et al. Evaluation of the potential in vivo genotoxicity of quercetin. Mutat Res 654 (2008) 38-44
33. No H.N., Kwon H., Park Y.G., Cheon C., Park J.S., Park T., et al. Dietary quercetin inhibits 1, 2-dimethylhydrazine induced liver DNA damage without altering colon DNA damage or precancerous lesion formation in rats. Nutr Res 27 (2007) 659-664
34. Boots A.W., Haenen G.R., and Bast A. Health effects of quercetin: from antioxidant to nutraceutical. Eur J Pharmacol 585 (2008) 325-337
35. Thangasamy T., Sittadjody S., and Burd R. Quercetin: a potential complementary and alternative cancer therapy. Complementary and Alternative Therapies and the Aging Population (2009) 563-584